Healthcare Professionals
ON BEHALF OF THE FMWC,
Thank You
FOR YOUR COMMITMENT TO PROTECTING NEWBORNS FROM RSV DISEASE.
ON BEHALF OF THE FMWC,
FOR YOUR COMMITMENT TO PROTECTING NEWBORNS FROM RSV DISEASE.
ON BEHALF OF THE FMWC,
FOR YOUR COMMITMENT TO PROTECTING NEWBORNS FROM RSV DISEASE.
Stay up to date on the latest information about protecting newborns from RSV disease through the links below.
Scientific Publications and News Articles
Scientific Publications and News Articles
“The time is now. We have new options, we have the luxury of learning from other countries’ experiences, and we need to act now to protect infants, and we will.”
– Dr. Vivien Brown, Family Physician, Toronto, Co-Chair FMWC Maternal RSV Task Force
CURRENT GUIDELINES AND POSITION STATEMENTS
- FMWC (Federation of Medical Women of Canada) Respiratory Syncytial Virus (RSV): Recommendations for the Prevention of Disease in Infants for the 2024 – 2025 RSV Season
- CPS (Canadian Paediatric Society) Respiratory syncytial virus (RSV) prevention strategies for the 2024-2025 viral respiratory illness season
- SOGC (Society of Obstetricians and Gynecologists of Canada)
• SOGC Statement on RSV Immunization to Prevent Infant RSV Infection - NACI (National Advisory Committee on Immunization
• Statement on the prevention of respiratory syncytial virus (RSV) disease in infants. 2024.• Summary of the National Advisory Committee on Immunization (NACI) Statement of May 17, 2024.
- CDC (Centers for Disease Control and Prevention)
• Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023 | MMWR (cdc.gov) - UK Government Joint Committee on Vaccination and Immunization
• Respiratory syncytial virus (RSV) immunisation programme for infants and older adults: JCVI full statement, 11 September 2023 – GOV.UK (www.gov.uk)• National RSV vaccination programme announced – GOV.UK (www.gov.uk)
CURRENT GUIDELINES AND POSITION STATEMENTS
- FMWC (Federation of Medical Women of Canada) Respiratory Syncytial Virus (RSV): Recommendations for the Prevention of Disease in Infants for the 2024 – 2025 RSV Season
- CPS (Canadian Paediatric Society) Respiratory syncytial virus (RSV) prevention strategies for the 2024-2025 viral respiratory illness season
- SOGC (Society of Obstetricians and Gynecologists of Canada)• SOGC Statement on RSV Immunization to Prevent Infant RSV Infection
- NACI (National Advisory Committee on Immunization
• Statement on the prevention of respiratory syncytial virus (RSV) disease in infants. 2024.• Summary of the National Advisory Committee on Immunization (NACI) Statement of May 17, 2024.
- CDC (Centers for Disease Control and Prevention)
• Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023 | MMWR (cdc.gov) - UK Government Joint Committee on Vaccination and Immunization • Respiratory syncytial virus (RSV) immunisation programme for infants and older adults: JCVI full statement, 11 September 2023 – GOV.UK (www.gov.uk)
• National RSV vaccination programme announced – GOV.UK (www.gov.uk)
CURRENT GUIDELINES AND POSITION STATEMENTS
- FMWC (Federation of Medical Women of Canada) Respiratory Syncytial Virus (RSV): Recommendations for the Prevention of Disease in Infants for the 2024 – 2025 RSV Season
- CPS (Canadian Paediatric Society) Respiratory syncytial virus (RSV) prevention strategies for the 2024-2025 viral respiratory illness season
- SOGC (Society of Obstetricians and Gynecologists of Canada)• SOGC Statement on RSV Immunization to Prevent Infant RSV Infection
- NACI (National Advisory Committee on Immunization
• Statement on the prevention of respiratory syncytial virus (RSV) disease in infants. 2024.• Summary of the National Advisory Committee on Immunization (NACI) Statement of May 17, 2024.
- CDC (Centers for Disease Control and Prevention)
• Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023 | MMWR (cdc.gov) - UK Government Joint Committee on Vaccination and Immunization
• Respiratory syncytial virus (RSV) immunisation programme for infants and older adults: JCVI full statement, 11 September 2023 – GOV.UK (www.gov.uk)• National RSV vaccination programme announced – GOV.UK (www.gov.uk)
“We see our pregnant patients on a regular basis and offer other routine vaccines. To give every infant the chance for protection from RSV this 2024 -2025 season, we have the ideal opportunity to educate, inform and offer the option for maternal RSV vaccination between 32 and 36 weeks’ gestation.”
– Dr. Shelley Ross, Family Physician, Burnaby, Co-Chair FMWC Maternal RSV Task Force
